VIRAL DYNAMICS AND EARLY VIRAL RESPONSE AT WEEK 4 IN CHRONIC HEPATITIS C PATIENTS TREATED WITH PEGINTERFERON α2B AND RIBAVIRIN

被引：0
|
作者：
Loaeza del Castillo, Aurora [1 ]
Sixtos-Alonso, S. [1 ]
Sanchez-Avila, F. [1 ]
Uribe, M. [1 ]
机构：
[1] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Mexico City, DF, Mexico
来源：
HEPATOLOGY | 2009年 / 50卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1436
引用
收藏
页码：965A / 965A
页数：1
相关论文
共 50 条
  • [21] Sustained Viral Response to Pegylated Interferon α-2b and Ribavirin in Chronic Hepatitis C Refractory to Prior Treatment
    A. Mathew
    L. P. Peiffer
    K. Rhoades
    T. McGarrity
    Digestive Diseases and Sciences, 2006, 51 : 1956 - 1961
  • [22] Biochemical, histologic and viral factors influencing early (EVR) and sustained (SVR) virological response in patients with chronic hepatitis C treated with peginterferon plus ribavirin
    Georgescu, E. F.
    Georgescu, M.
    Niculescu, M.
    Florescu, G.
    Dobrinescu, A.
    Florea, L.
    Vancica, L.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2008, 23 : A31 - A31
  • [23] Viral kinetics in patients with chronic hepatitis C treated with standard or peginterferon α2a
    Zeuzem, S
    Herrmann, E
    Lee, JH
    Fricke, J
    Neumann, AU
    Modi, M
    Colucci, G
    Roth, WK
    GASTROENTEROLOGY, 2001, 120 (06) : 1438 - 1447
  • [24] Viral Response at Week 2 as a Predicitive Factor for Rvr in Chronic Hepatitis C Genotype 1 Infection Treated With Peginterferon Alfa-2A (PEG) and Ribavirin (RBV)
    Mauss, Stefan
    Lutz, Thomas
    Boeker, Klaus H.
    Link, Ralph
    Moog, Gero
    Stoehr, Albrecht D.
    Baumgarten, Axel
    Heyne, Renate
    Eisenbach, Christoph
    Teuber, Gerlinde
    Weber, Bernd
    Schott, Eckart
    Hillenbrand, Heribert
    Alshuth, Ulrich
    Hueppe, Dietrich
    Buggisch, Peter
    GASTROENTEROLOGY, 2012, 142 (05) : S958 - S958
  • [25] Sustained viral response (SVR) with Peginterferon alfa-2a and ribavirin in patients with chronic hepatitis C who were non responders (NR) to Peginterferon alfa-2b and ribavirin
    Gitlin, N
    Muther, KD
    HEPATOLOGY, 2004, 40 (04) : 343A - 343A
  • [26] Clinical implications of testing viral response during ribavirin and peginterferon alfa-2b treatment for chronic hepatitis C
    Wong, JB
    Davis, GL
    McHutchison, JG
    Manns, MP
    Albrecht, JK
    HEPATOLOGY, 2002, 36 (04) : 281A - 281A
  • [27] Early hepatitis C viral RNA decline during therapy with interferon α-2B and ribavirin in patients with chronic hepatitis C without sustained response to prior interferon.
    Min, A
    Jones, J
    Esposito, S
    Lebovics, E
    Klion, F
    Jacobson, I
    Goldman, I
    Geders, J
    Tobias, H
    Branch, A
    Bodenheimer, H
    GASTROENTEROLOGY, 1998, 114 (04) : A1302 - A1302
  • [28] Viral factors influencing the response to the combination therapy of peginterferon plus ribavirin in chronic hepatitis C
    Shinya Maekawa
    Nobuyuki Enomoto
    Journal of Gastroenterology, 2009, 44 : 1009 - 1015
  • [29] Viral factors influencing the response to the combination therapy of peginterferon plus ribavirin in chronic hepatitis C
    Maekawa, Shinya
    Enomoto, Nobuyuki
    JOURNAL OF GASTROENTEROLOGY, 2009, 44 (10) : 1009 - 1015
  • [30] Randomized trial of peginterferon α-2a plus ribavirin versus peginterferon α-2b plus ribavirin for chronic hepatitis C in Japanese patients
    Shiho Miyase
    Katsuki Haraoka
    Yoshihiro Ouchida
    Yuko Morishita
    Shigetoshi Fujiyama
    Journal of Gastroenterology, 2012, 47 : 1014 - 1021
12345